Generic Chantix Launched Following Recall of Name Brand Drug Due To Toxic Contaminant
The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.
Tag Archives: Pfizer
-
-
Pfizer Recalling All Chantix Batches Due to Carcinogen in Smoking Cessation Drug
Pfizer has issued a full recall of all Chantix nationwide, due to the presence of potentially cancer-causing chemicals.
-
Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects
The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as…
-
Chantix Class Action Lawsuit Filed Over Cancer-Causing Impurity
A recent Chantix recall has resulted in a class action lawsuit against Pfizer, which claims the company sold a defective drug to consumers which put them at an increased risk…
-
More Chantix Recalled Due To Cancer-Causing Chemicals, As N-Nitroso Varenicline Found in Additional Lots
Pfizer is recalling four additional lots of Chantix due to high levels of a potentially cancer-causing contaminant.
-
Group of Six Nexium, Prilosec Kidney Injury Lawsuits To Be Set For Early Trials in Federal MDL
A federal judge has scheduled the first bellwether trial for Nexium, Prilosec, and Prevacid lawsuits for early 2022.
-
Experts, FDA Concerned Xeljanz Heart and Cancer Problems May Affect Similar Arthritis Drugs
Drugs in the same class as Xeljanz face increased scrutiny over concerns they may carry similar heart and cancer risks such as those suspected of plaguing the arthritis drug.
-
Chantix Recall Expanded To U.S. Products Due To N-Nitroso Varenicline Contamination
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.
-
Pfizer Suspends Chantix Distribution Due to Presence of Cancer-Causing NDMA
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.
-
FDA Worried Jakafi May Have Cancer, Heart Risks Similar to Xeljanz
The FDA has delayed an expanded approval for the drug Jakafi, potentially due to concerns over heart and cancer risks linked to Pfizer's Xeljanz, a similar drug.